专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP2078516B1 Implant for treating ocular disorders 有权
标题翻译：装置和方法，用于治疗青光眼的
公开(公告)号：EP2078516B1
公开(公告)日：2013-01-02
申请号：EP09158524.0
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905

2. 发明公开

EP2078516A2 Implant for treating ocular disorders 有权
标题翻译：用于治疗眼部疾病的植入物
公开(公告)号：EP2078516A2
公开(公告)日：2009-07-15
申请号：EP09158524.0
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of acqueous veins.
摘要翻译：披露了用于治疗青光眼的手术方法和相关医疗装置。该方法包括小梁旁路手术，其涉及使用固定植入物绕过患病的小梁网。 seton种植体用于防止称为填充的愈合过程，该过程倾向于关闭在小梁网中手术形成的开口。手术方法和新型植入物针对小梁网，这是青光眼外流阻力的主要部位。除了在小梁网水平绕过患病的小梁网外，现有的流出路径也被使用或恢复。固定器植入物通过小梁网定位，使得固定器植入物的入口端暴露于眼的前房并且出口端定位在小梁网外表面附近的流体收集通道中或直至水脉的水平。

3. 发明公开

EP2260803A3 Ocular implant system for treating glaucoma 有权
标题翻译：用于治疗青光眼的眼植入物系统
公开(公告)号：EP2260803A3
公开(公告)日：2011-03-16
申请号：EP10179000.4
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of acqueous veins.

4. 发明授权

EP2260803B1 Ocular implant system for treating glaucoma 有权
标题翻译：用于治疗青光眼的眼植入物系统
公开(公告)号：EP2260803B1
公开(公告)日：2015-07-22
申请号：EP10179000.4
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007 , A61F9/00
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905

5. 发明公开

EP2260803A2 Ocular implant system for treating glaucoma 有权
标题翻译： Okulares Implantatsystem zur Behandlung von Glaukoma
公开(公告)号：EP2260803A2
公开(公告)日：2010-12-15
申请号：EP10179000.4
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of acqueous veins.
摘要翻译：公开了用于治疗青光眼的手术方法和相关的医疗装置。该方法包括小梁旁路手术，其涉及利用植入物绕过患病的小梁网。镶嵌植入物用于防止称为填充的愈合过程，其具有在小梁网中关闭手术产生的开口的趋势。手术方法和新型植入物是针对小梁网，其是青光眼流出阻力的主要部位。除了在小梁网的水平绕过患病的小梁网，还使用或恢复现有的流出路径。镶嵌植入物定位穿过小梁网，使得植入植入物的入口端暴露于眼睛的前房，并且出口端位于小梁网的外表面周围的流体收集通道中，或直到水静脉水平。

6. 发明公开

EP2078516A3 Implant for treating ocular disorders 有权
标题翻译：装置和方法，用于治疗青光眼的
公开(公告)号：EP2078516A3
公开(公告)日：2009-11-04
申请号：EP09158524.0
申请日：2001-03-08
申请人： Glaukos Corporation
发明人： Bergheim, Olav B. , Gharib, Morteza
IPC分类号： A61F9/007
CPC分类号： A61F9/00781 , A61F9/0017 , A61F9/007 , A61F2009/00891 , A61F2250/0067 , A61K9/0051 , A61M27/002 , A61M2210/0612 , Y10S623/905
摘要： Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of acqueous veins.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式